A Study to Compare How Effective is Encorafenib Plus Binimetinib in Real-world and Clinical Trial Settings

Clinical trial NCT05954546 · COMPLETED

Trial details

NCT number: NCT05954546
Sponsor: Pfizer
Status: COMPLETED
Study type: OBSERVATIONAL

Metastatic Melanoma

Start date: 2023-07-21
Primary completion: 2023-12-31
Enrollment: 275

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.